Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2011-04-19
2011-04-19
Kim, Jennifer M (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S576000
Reexamination Certificate
active
07928146
ABSTRACT:
Fecal incontinence and anal itch can be treated by administration, more particularly by local application to the anus, of an αadrenergic blocker, nitric oxide synthase inhibitor, prostaglandin F2α, dopamine, morphine, β-blockers, and 5-Hydroxytryptamine. The patients who benefit most from the invention are those who have a normal or low maximum anal resting pressure and a structurally intact internal anal sphincter muscle, and patients who have had major bowel resection and reanastomisis.
REFERENCES:
patent: 4292300 (1981-09-01), Byrne et al.
patent: 5213808 (1993-05-01), Bar-Shalom et al.
patent: 5401776 (1995-03-01), Laurent et al.
patent: 5436009 (1995-07-01), Jauw et al.
patent: 5595753 (1997-01-01), Hechtman
patent: 6635678 (2003-10-01), Kamm et al.
patent: WO 91/00730 (1991-01-01), None
patent: WO-96/14828 (1996-05-01), None
P. Enck et al.; Internist, vol. 34, No. 1, 1993, pp. 51-58.
David E. Burleigh et al.; Gastroenterology, vol. 84, No. 2, 1983.
Shigeru Yamato et al.; J. Clin. Invest., vol. 86, No. 2, 1990, pp. 424-429.
Herbert B. Hechtmann et al.; Archives of Surgery, vol. 131, No. 7, 1996, pp. 775-778.
Satish Rattan et al.; Am. J. Physiol., vol. 262, No. 1, 1992, pp. 107-112.
Gut, 1991, vol. 32, pp. 345-346.
Br. J. Surg., 1992, vol. 79, August, pp. 829-832.
Coloproctology and the Pelvic Floor, 2ndEdition, 1992, Chapter 3, pp. 37-53.
New England Journal of Medicine, Apr. 1992, pp. 1002-1007.
Gastroenterology in Practice, Summer 1995, pp. 18-21.
Dig. Dis., 1990, vol. 8, pp. 179-188.
Digestive Diseases and Sciences, vol. 38, No. 11, Nov. 1993, pp. 1961-1969.
Br. J. Surg., 1990, vol. 77, Dec., pp. 1342-1344.
Gutierrez et al.; pp. 363-373.
Surgery, Mar. 1990, vol. 107, No. 3, pp. 311-315.
Drug Facts and Comparisons, Aug. 1987, pp. 538-540.
Patient Information Leaflet for Betnovate Rectal Ointment, Oct. 1992.
Martindale, The Extra Pharmacopoeia, 1996, pp. 1585-1586.
Wilkinson et al, Contact Dematitis, “Allergic Contact Dermatits from Phenylephrine in a Rectal Ointment”, 1993, 29:100-101.
Martindale, The Complete Drug Reference, On-line Version, Betnovate Rectal Ointment,, 2007.
Martindale, The Comple Drug Reference, On-Line Version, Hemocaine, 2007.
Martindale, The Complete Drug Reference, On-Line Version, Hemet, 2007.
Martindale, the Complete Drug Reference, On-Line Version, A-Caine, 2007.
Martindale, The Complete Drug Reference, On-Line Version, Rectagene Medicated Rectal Balm, 2007.
Carapeti et al., “British Journal of Sugery”, 1999, pp. 86, 267-270.
Kamm Michael A.
Phillips Robin K. S.
Bacon & Thomas PLLC
Kim Jennifer M
S.L.A. Pharma AG
LandOfFree
Pharmaceutical composition for treating fecal incontinence... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for treating fecal incontinence..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for treating fecal incontinence... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2694190